KLOW vs Glow: Same Healing Base, One Extra Peptide (KPV)

KLOW and Glow are the two most popular pre-mixed “healing blend” vials, and the honest comparison is simpler than most: KLOW is Glow with one extra peptide added. Both are GHK-Cu-dominant blends sold as a single reconstitutable vial. Glow (glow) is GHK-Cu + BPC-157 + TB-500; KLOW (klow) is that exact base plus KPV, an anti-inflammatory tripeptide. (Because of that, the same KLOW formula also circulates under the name “Clow.”)

TL;DR: Glow is a three-peptide skin-and-healing blend (GHK-Cu 50 mg + BPC-157 10 mg + TB-500 10 mg). KLOW adds KPV 10 mg for anti-inflammatory coverage. Choose Glow for skin, hair, collagen, and general recovery; choose KLOW when there is an inflammatory component — inflammatory skin, gut issues, or autoimmune-adjacent concerns. Same dosing pattern, same GHK-Cu backbone.

Research-use disclosure: For educational purposes only, not medical advice. None of these peptides is FDA-approved; all are research-use-only. Dosing reflects community protocols. VialBase may earn a commission on vendor links, which does not influence the content here.

At a Glance

The entire difference is the KPV line. Everything else — the copper-peptide backbone, the BPC-157/TB-500 repair pair, the dosing, the single-vial convenience — is shared.

The Shared Base: GHK-Cu + BPC-157 + TB-500

Both blends are built on the same three-peptide healing core:

• GHK-Cu is the backbone by mass (50 mg of both vials). It delivers copper to skin, hair, and wound tissue and drives collagen and elastin synthesis — the “renewal” engine of the blend.
• BPC-157 adds local angiogenesis and growth-factor drive at the tissue level.
• TB-500 contributes systemic actin-driven cell migration into recovering tissue.

Together, that core covers skin renewal from three angles — extracellular matrix, vascular, and cellular migration. This is the whole of Glow, and three-quarters of KLOW.

The Difference: KPV

KLOW layers KPV — a short anti-inflammatory tripeptide (the C-terminal fragment of α-MSH) — on top of the Glow base. KPV’s role is inflammation control: it acts on NF-κB signaling and is used for inflammatory skin conditions, gut/GI inflammation, and autoimmune-adjacent concerns. Adding it turns a skin-and-healing blend into a skin-healing-and-anti-inflammatory blend.

That single addition is the entire decision. If the goal is cosmetic (skin tightening, hair, collagen) or general soft-tissue recovery, the KPV line is optional and Glow suffices. If the concern has an inflammatory driver — inflammatory acne or redness, IBD-like gut symptoms, eczema-adjacent skin — KLOW’s KPV is the reason to pick it.

Which Should You Choose?

• Skin, hair, collagen, anti-aging, general healing → Glow. The GHK-Cu + BPC-157 + TB-500 core is purpose-built for this, and you are not paying for a peptide you do not need.
• Any inflammatory component (inflammatory skin, gut issues, autoimmune-adjacent) → KLOW. KPV’s anti-inflammatory action is the differentiator.
• Want the broadest single-vial coverage → KLOW. It contains everything Glow does plus KPV, so it is the more complete blend if you are unsure — at a modestly higher cost.
• Need independent control of one peptide → neither blend. Both are fixed-ratio; dose the components separately (see the individual compound pages) if you need to tune, for example, TB-500 weekly loading independently.

For the full protocols with per-component unit math, see the KLOW dosage chart and the Glow dosage chart, or the KLOW and Glow stack profiles.

Dosing

Both use the same approach: reconstitute with 2 mL bacteriostatic water and inject 10–20 units (0.1–0.2 mL) subcutaneously daily, starting at 10 units to assess tolerance. Because both contain TB-500 (~14-day half-life), some users dose every other day to moderate TB-500 accumulation. Store reconstituted vials at 2–8 °C and use within 28 days. Full tiered protocols are on the dosage-chart pages linked above.

Frequently Asked Questions

What is the difference between KLOW and Glow? KLOW is Glow plus one extra peptide, KPV. Glow is a three-peptide blend — GHK-Cu, BPC-157, and TB-500 — for skin radiance, hair, collagen, and general healing. KLOW adds KPV, a dedicated anti-inflammatory tripeptide, on top of that same base, which makes it the better choice when there is an inflammatory component such as inflammatory skin conditions, gut issues, or autoimmune-adjacent concerns.

Is KLOW just Glow with KPV added? Essentially yes. Both are GHK-Cu-dominant healing blends with the same GHK-Cu, BPC-157, and TB-500 core. KLOW layers KPV on top for anti-inflammatory coverage — which is why the same KLOW formula also circulates under the name Clow. If you do not need the anti-inflammatory action, Glow covers the skin, hair, and healing use case.

Which is better for skin and anti-aging, KLOW or Glow? For pure skin, hair, and collagen goals, Glow is sufficient — GHK-Cu drives the copper-peptide collagen and elastin work while BPC-157 and TB-500 add angiogenesis and cell migration. KLOW is the better pick when the skin concern is inflammatory, where KPV’s anti-inflammatory action helps.

Do KLOW and Glow use the same dosing? They follow the same pattern: reconstitute the vial with 2 mL bacteriostatic water and inject 10–20 units (0.1–0.2 mL) subcutaneously daily, titrating up from 10 units. Glow is ~70 mg and KLOW is ~80 mg, but the practical draw is the same. See the KLOW and Glow dosage charts for per-component unit math.

Are KLOW and Glow FDA-approved? No. Every peptide in both blends is research-use-only in the US, and none is on the 503A bulks list or in any FDA interim compounding category. These are community blends; dosing guides are a starting point, not medical advice. Avoid with active cancer or during pregnancy.